Stay ahead with the latest from NHTAโจInsights and updates shaping the future of Market Access, Nordic RWE, and Policy.
Insights
NICE approves givinostat for Duchenne muscular dystrophy
NICE has issued final draft guidance recommending the treatment for people aged 6 and over who can walk or stand at the start of treatment,…
Read more TLV to host seminar on U.S. MFN policy
TLV will host a seminar on the impact of U.S. MFN policy on Swedenโs pricing system. The webinar is part of TLVโs assignment to follow…
Read more 
